MECHANISMS FOR KETOAMIDE ESCAPE IN VAL55 VARIANTS OF THE HCV NS3/4A PROTEASE DOMAIN

被引：0
|
作者：
Welsch, C. [1 ,2 ,3 ]
Schweizer, S. [4 ,5 ]
Shimakami, T. [3 ]
Antes, I. [4 ,5 ]
Zeuzem, S. [1 ]
Lemon, S. [3 ]
机构：
[1] Goethe Univ Frankfurt, Med Klin 1, Frankfurt, Germany
[2] Max Planck Inst Informat, Saarbrucken, Germany
[3] Univ N Carolina, Chapel Hill, NC USA
[4] Tech Univ Munich, Munich, Germany
[5] Kanazawa Univ, Kanazawa, Ishikawa, Japan
来源：
JOURNAL OF HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
10.1016/S0168-8278(12)61226-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1214
引用
收藏
页码：S482 / S482
页数：1
相关论文
共 50 条
  • [21] Hepatitis C virus NS3/4A protease
    Kwong, AD
    CURRENT OPINION IN INFECTIOUS DISEASES, 1997, 10 (06) : 485 - 490
  • [22] Synthetic bulky NS4A peptide variants bind to and inhibit HCV NS3 protease
    El-Araby, Moustafa E.
    Omar, Abdelsattar M.
    Soror, Sameh H.
    Arold, Stefan T.
    Khayat, Maan T.
    Asfour, Hani Z.
    Bamane, Faida
    Elfaky, Mahmoud A.
    JOURNAL OF ADVANCED RESEARCH, 2020, 24 : 251 - 259
  • [23] Unraveling the mechanisms of Sofosbuvir resistance in HCV NS3/4A protease: Structural and molecular simulation-based insights
    Shahab, Muhammad
    Khan, Abbas
    Khan, Salman Ali
    Zheng, Guojun
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 267
  • [24] Discovery and Development of Simeprevir (TMC435), a HCV NS3/4A Protease Inhibitor
    Rosenquist, Asa
    Samuelsson, Bertil
    Johansson, Per-Ola
    Cummings, Maxwell D.
    Lenz, Oliver
    Raboisson, Pierre
    Simmen, Kenny
    Vendeville, Sandrine
    de Kock, Herman
    Nilsson, Magnus
    Horvath, Andras
    Kalmeijer, Ronald
    de la Rosa, Guy
    Beumont-Mauviel, Maria
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (05) : 1673 - 1693
  • [25] Discovering novel anti-HCV compounds with inhibitory activities toward HCV NS3/4A protease
    Ye Yu
    Jing-feng Jing
    Xian-kun Tong
    Pei-lan He
    Yuan-chao Li
    You-hong Hu
    Wei Tang
    Jian-ping Zuo
    Acta Pharmacologica Sinica, 2014, 35 : 1074 - 1081
  • [26] SEQUENCE EVOLUTION OF THE HCV NS3/4A PROTEASE DURING ACUTE HEPATITIS C VIRUS (HCV) INFECTION
    Dietz, J.
    Lutz, T.
    Knecht, G.
    Gute, P.
    Nehring, A.
    Raziorrouh, B.
    Diepolder, H.
    Zeuzem, S.
    Sarrazin, C.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S408 - S408
  • [27] A wide range of NS3/4A protease catalytic efficiencies in HCV-infected individuals
    Franco, Sandra
    Clotet, Bonaventura
    Martinez, Miguel Angel
    VIRUS RESEARCH, 2008, 131 (02) : 260 - 270
  • [28] Discovering novel anti-HCV compounds with inhibitory activities toward HCV NS3/4A protease
    Yu, Ye
    Jing, Jing-feng
    Tong, Xian-kun
    He, Pei-lan
    Li, Yuan-chao
    Hu, You-hong
    Tang, Wei
    Zuo, Jian-ping
    ACTA PHARMACOLOGICA SINICA, 2014, 35 (08) : 1074 - 1081
  • [29] Inhibitors of hepatitis C virus NS3/4A: α-Ketoamide based macrocyclic inhibitors
    Avolio, Salvatore
    Robertson, Keith
    Hernando, Jose Ignacio Martin
    DiMuzio, Jillian
    Summa, Vincenzo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (08) : 2295 - 2298
  • [30] Hepatitis C virus NS3/4a protease inhibitors
    McCauley, John A.
    Rudd, Michael T.
    CURRENT OPINION IN PHARMACOLOGY, 2016, 30 : 84 - 92
12345